Recently 45 Postdocs and PhD candidates attended the first Interactive career day organized by Janssen Pharmaceutica, to learn more about career perspectives and R&D activities that may lead to ideas and potential future collaboration on a longer term.
12 Participants were selected to showcase their research in a 3-minute pitch. All other participants were invited to present a poster. A jury selected the 3 best pitches and 3 best posters. These researchers will be invited to have an individual session with Janssen Pharmaceutica.
- Marilen Benner: Healthy uterus, healthy placenta, healthy offspring
- Jeroen Slaat: Tumor cells.
- Kinga Matula: Single-cell detection of metastatic cancer
- Michael Teders et al.: The Energy-Transfer-Enabled Biocompatible Disulfide-Ene Reaction
- Mike Marvin Ruth, Jodie Schilkraut et al.: A hollow-fiber infection model supported drug discovery pipeline for antmycobacterial drugs
- Elena Daines, Peer van Duppen: Chemical reaction networks in a dynamic environment
Related news items
Frank Walboomers 25-years work anniversary at Radboudumc17 September 2020
Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.read more
Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes17 September 2020
Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.read more
Annette Schenck appointed professor of Translational Genetics17 September 2020
Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.read more
Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients17 September 2020
Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.read more
Radboudumc does large-scale research on systemic sclerosis10 September 2020
In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.read more